Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Enhancing Chemo and Radiation for Prostate Cancer with Dr. Greg van Wyk Noxopharm-TRANSCRIPT
Download PDFJun 25, 2019
Dr. Greg van Wyk, CMO and recently appointed CEO, Noxopharm talks about the Company's current milestones and upcoming news related to its lead clinical drug candidate, Veyonda, a chemotherapy and radiation enhancer that is being studied in men with late stage metastatic prostate cancer and that may have broad...
Jun 25, 2019
Dr. Greg van Wyk, CMO and recently appointed CEO, Noxopharm talks about the Company's current milestones and upcoming news related to its lead clinical drug candidate, Veyonda, a chemotherapy and radiation enhancer that is being studied in men with late stage metastatic prostate cancer and that may have broad...
Jun 19, 2019
Terri Wingham, Founder, A Fresh Chapter was diagnosed with an aggressive form of cancer when she was in her 30's. As a result she founded A Fresh Chapter, giving cancer survivors and caregivers an opportunity to travel to foreign and US destinations to get outside of their comfort zone and discover new possibilities,...
Targeting Gastrointestinal Disorders and Related Pain with Dr. Preston Klassen Arena Pharmaceuticals
Jun 12, 2019
Preston Klassen, MD Chief Medical Officer, Arena Pharmaceuticals talks about the challenges of treating Inflammatory Bowel Diseases (IBD) and Arena's developmental therapies for ulcerative colitis and Crohn's disease. We also talk about the development of a treatment for related gastrointestinal pain with a...
Unique Therapy for Multiple Inflammatory Diseases with Dr. Jean-Marc Steens Abivax--TRANSCRIPT
Download PDFJun 4, 2019
Dr. Jean-Marc Steens, Chief Medical Officer, Abivax reports on clinical results that continue to show advances in the chronic treatment and maintenance of moderate to severe ulcerative colitis using a new small molecule ABX464 in an oral treatment and potential applications for other inflammatory and neurological...